GPSM2

G protein signaling modulator 2, the group of Tetratricopeptide repeat domain containing

Basic information

Region (hg38): 1:108875350-108934545

Previous symbols: [ "DFNB82" ]

Links

ENSG00000121957NCBI:29899OMIM:609245HGNC:29501Uniprot:P81274AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Chudley-McCullough syndrome (Strong), mode of inheritance: AR
  • Chudley-McCullough syndrome (Definitive), mode of inheritance: AR
  • Chudley-McCullough syndrome (Strong), mode of inheritance: AR
  • Chudley-McCullough syndrome (Strong), mode of inheritance: AR
  • Chudley-McCullough syndrome (Moderate), mode of inheritance: AR
  • hearing loss, autosomal recessive (Supportive), mode of inheritance: AR
  • Chudley-McCullough syndrome (Supportive), mode of inheritance: AR
  • Chudley-McCullough syndrome (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Chudley-McCullough syndromeARAudiologic/OtolaryngologicEarly recognition and treatment of hearing impairment may improve outcomes, including speech and language developmentAudiologic/Otolaryngologic; Neurologic20602914; 20602914

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the GPSM2 gene.

  • not provided (6 variants)
  • Chudley-McCullough syndrome (6 variants)
  • Hearing loss, autosomal recessive (2 variants)
  • Rare genetic deafness (2 variants)
  • not specified (1 variants)
  • Inborn genetic diseases (1 variants)
  • GPSM2-related disorder (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the GPSM2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
4
clinvar
24
clinvar
28
missense
85
clinvar
6
clinvar
91
nonsense
4
clinvar
5
clinvar
9
start loss
0
frameshift
4
clinvar
6
clinvar
2
clinvar
12
inframe indel
2
clinvar
2
splice donor/acceptor (+/-2bp)
2
clinvar
6
clinvar
1
clinvar
9
splice region
1
4
6
11
non coding
22
clinvar
33
clinvar
26
clinvar
81
Total 10 17 114 65 26

Highest pathogenic variant AF is 0.0000592

Variants in GPSM2

This is a list of pathogenic ClinVar variants found in the GPSM2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-108876991-G-C Chudley-McCullough syndrome Uncertain significance (Jan 13, 2018)291689
1-108877008-C-G Chudley-McCullough syndrome Uncertain significance (Jan 13, 2018)291690
1-108877024-C-T Chudley-McCullough syndrome Uncertain significance (Jan 13, 2018)876503
1-108877036-G-C Chudley-McCullough syndrome Uncertain significance (Jan 13, 2018)291691
1-108877048-C-T Chudley-McCullough syndrome Likely benign (Apr 27, 2017)291692
1-108877051-G-A Chudley-McCullough syndrome Uncertain significance (Jan 12, 2018)291693
1-108877080-C-G Chudley-McCullough syndrome Uncertain significance (Jan 13, 2018)291694
1-108877108-G-A Chudley-McCullough syndrome Uncertain significance (Jan 13, 2018)291695
1-108877120-C-T Chudley-McCullough syndrome Uncertain significance (Jan 13, 2018)291696
1-108877161-C-T Chudley-McCullough syndrome Uncertain significance (Apr 27, 2017)873607
1-108877171-C-A Chudley-McCullough syndrome Uncertain significance (Jan 12, 2018)291697
1-108877189-C-A Chudley-McCullough syndrome Uncertain significance (Mar 30, 2018)873608
1-108877219-C-T Chudley-McCullough syndrome • not specified Benign/Likely benign (Feb 11, 2020)291698
1-108885096-C-G Likely benign (Aug 17, 2018)1175522
1-108885259-T-C not specified Likely benign (Feb 04, 2016)382922
1-108885274-G-A Chudley-McCullough syndrome Uncertain significance (Aug 22, 2018)632077
1-108885278-T-A Chudley-McCullough syndrome Uncertain significance (Jan 13, 2018)291699
1-108885521-C-T not specified Uncertain significance (Sep 03, 2013)179233
1-108885533-A-T Chudley-McCullough syndrome Likely benign (Mar 29, 2024)3065632
1-108885545-T-C Uncertain significance (Sep 30, 2019)1308983
1-108885558-T-C Uncertain significance (Dec 28, 2022)2507280
1-108885572-G-A Uncertain significance (Sep 18, 2021)1402146
1-108885627-G-A Benign (Jun 24, 2018)1269298
1-108885722-G-GT Benign (Mar 29, 2019)1265073
1-108885733-T-C Likely benign (Oct 28, 2018)1189415

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
GPSM2protein_codingprotein_codingENST00000406462 1459196
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
7.70e-110.96812560701411257480.000561
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.262973640.8150.00001884515
Missense in Polyphen106148.890.711961783
Synonymous1.851011280.7920.000006451280
Loss of Function2.212236.40.6050.00000217432

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0008250.000824
Ashkenazi Jewish0.00009920.0000992
East Asian0.000.00
Finnish0.0002310.000231
European (Non-Finnish)0.0008190.000818
Middle Eastern0.000.00
South Asian0.0003920.000392
Other0.0009810.000978

dbNSFP

Source: dbNSFP

Function
FUNCTION: Plays an important role in mitotic spindle pole organization via its interaction with NUMA1 (PubMed:11781568, PubMed:15632202, PubMed:21816348). Required for cortical dynein- dynactin complex recruitment during metaphase (PubMed:22327364). Plays a role in metaphase spindle orientation (PubMed:22327364). Plays also an important role in asymmetric cell divisions (PubMed:21816348). Has guanine nucleotide dissociation inhibitor (GDI) activity towards G(i) alpha proteins, such as GNAI1 and GNAI3, and thereby regulates their activity (By similarity). {ECO:0000250|UniProtKB:Q8VDU0, ECO:0000269|PubMed:11781568, ECO:0000269|PubMed:15632202, ECO:0000269|PubMed:21816348, ECO:0000269|PubMed:22327364}.;
Pathway
Signaling by GPCR;Signal Transduction;G alpha (i) signalling events;GPCR downstream signalling (Consensus)

Intolerance Scores

loftool
0.293
rvis_EVS
0.02
rvis_percentile_EVS
55.69

Haploinsufficiency Scores

pHI
0.565
hipred
Y
hipred_score
0.564
ghis
0.574

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
gene_indispensability_pred
E
gene_indispensability_score
0.769

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Gpsm2
Phenotype
cellular phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Gene ontology

Biological process
establishment of mitotic spindle orientation;mitotic spindle organization;G protein-coupled receptor signaling pathway;Ran protein signal transduction;regulation of catalytic activity;cell division;maintenance of centrosome location;regulation of mitotic spindle organization;positive regulation of protein localization to cell cortex;positive regulation of spindle assembly
Cellular component
cytoplasm;centrosome;cytosol;cell cortex;lateral plasma membrane;protein-containing complex;mitotic spindle pole;lateral cell cortex;cell cortex region
Molecular function
nucleotide binding;G-protein alpha-subunit binding;GDP-dissociation inhibitor activity;protein binding;protein C-terminus binding;protein domain specific binding;identical protein binding;protein self-association;dynein complex binding